Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes

Critical Limb Ischemia (CLI) is common but uncommonly diagnosed. Improved recognition and early diagnostic markers for CLI are needed. Therefore, the aim of our study was to identify plasma biomarkers of CLI in patients with type 2 diabetes mellitus (T2DM). In this study, antibody-coated glass slide...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ju-yi, Yang, Xiao-yan, Wang, Xiu-fang, Jia, Xiong, Wang, Zhong-jing, Deng, Ai-ping, Bai, Xiang-li, Zhu, Lin, Li, Bing-hui, Feng, Zi-bo, Li, Ye, Wang, Ling, Jin, Si
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595823/
https://www.ncbi.nlm.nih.gov/pubmed/28900239
http://dx.doi.org/10.1038/s41598-017-11820-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595823/
https://www.ncbi.nlm.nih.gov/pubmed/28900239
http://dx.doi.org/10.1038/s41598-017-11820-x

Ejemplares similares